Most importantly, the authors confirmed increased HGF expression in stromal cells of BRAF-mutant melanoma patients undergoing BRAF-targeted treatment in vivo, which resulted in poor prognosis and decreased response to treatments [92]. Here, HGF is linked to melanoma.